Lyduine Collij graduated from the VU University Amsterdam in Neuropsychology and Clinical Neurosciences. She did her PhD at the Amsterdam University Medical Center as part of the European AMYPAD consortium, focused on amyloid-PET imaging in Alzheimer’s disease across the continuum. She subsequently did a two-year post-doc within the AMYPAD project, leading the disease modeling workgroup and providing project management. She is currently doing a postdoc at the BioFINDER group Lund University, supported by the MSCA and AARF grant to investigate disease heterogeneity in the context of clinical trial design.
Dr. Collij has received research support from GE Healthcare (paid to institution).
The data used in this activity is from the ADNI and AMYPAD consortia.
